Aniling completes the Retos Colaboración project with the development of a genetic and epigenetic test (GEUS-LB®) for the early detection of colorectal cancer in a blood sample. The Aniling -led project uses patented GEUS …
The health biotechnology magazine Farmabiotec reports on Aniling’s late achivements. Farmabiotec goes through Aniling’s IVD tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy and highlights their recent CE …
Yesterday was World Colorectal Cancer Day, the most frequent tumor in the Spanish Population and the second cause of cancer death worldwide, leading to almost 1 million deaths per year. …
Liquid biopsy tests provide access to tumor DNA in a minimally invasive way, offering great potential in oncology applications, including precision medicine, early cancer diagnosis and disease’s follow-up and monitoring. At Aniling, we have developed a new product, GEUS-LB, targeting …
